MBIO has been in the news 1000% more than usual
Jun 19, 2024, 12:32 AM
-46.35%
What does MBIO do
Mustang Bio, Inc., a clinical-stage biopharmaceutical company based in Worcester, Massachusetts, specializes in developing cell and gene therapies for hematologic cancers, solid tumors, and rare genetic diseases. The company, which went public in 2017, collaborates with notable medical centers like City of Hope and Fred Hutchinson Cancer Center to advance its CAR T therapy pipeline targeting various cancer markers.
MBIO has been in the news recently: Mustang Bio Inc's MBIO shares surged with high trading volume after positive Phase 1/2 trial results for MB-106 in blood cancer. In contrast, Quantum Corporation QMCO shares dropped due to disappointing FY24 results and lower-than-expected FY25 guidance.
📡️ Health Care
In The News
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.